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Most expression quantitative trait locus (eQTL) studies to date have been performed in heterogeneous tissues as opposed to
specific cell types. Tobetter understand the cell-type–specific regulatory landscape of humanmelanocytes, which give rise to
melanoma but account for <5%of typical human skin biopsies, we performed an eQTL analysis in primarymelanocyte cul-
tures from 106 newborn males. We identified 597,335 cis-eQTL SNPs prior to linkage disequilibrium (LD) pruning and 4997
eGenes (FDR<0.05). Melanocyte eQTLs differed considerably from those identified in the 44GTEx tissue types, including
skin. Over a third of melanocyte eGenes, including key genes in melanin synthesis pathways, were unique to melanocytes
compared to those of GTEx skin tissues or TCGAmelanomas. Themelanocyte data set also identified trans-eQTLs, including
those connecting a pigmentation-associated functional SNPwith four genes, likely through cis-regulation of IRF4.Melanocyte
eQTLs are enriched in cis-regulatory signatures found in melanocytes as well as in melanoma-associated variants identified
through genome-wide association studies. Melanocyte eQTLs also colocalized with melanoma GWAS variants in five known
loci. Finally, a transcriptome-wide association study usingmelanocyte eQTLs uncovered four novel susceptibility loci, where
imputed expression levels of five genes (ZFP90, HEBP1, MSC, CBWD1, and RP11-383H13.1) were associated with melanoma at
genome-wide significant P-values. Our data highlight the utility of lineage-specific eQTL resources for annotating GWAS
findings, and present a robust database for genomic research of melanoma risk and melanocyte biology.
[Supplemental material is available for this article.]
Expression quantitative trait locus (eQTL) analysis is a powerful
method to study gene expression and regulatory profiles in human
populations. Early studies mainly focused on eQTLs for whole
blood or blood-derived cells due to sample accessibility (Stranger
et al. 2007; Pickrell et al. 2010), and more recently, numerous
eQTL data sets derived from normal human tissues have been
made publicly available. Perhaps most notable are those from
the Genotype-Tissue Expression (GTEx) (The GTEx Consortium
2015) project representing >44 tissue types of hundreds of post-
mortem donors. These studies have collectively emphasized the
cell-type–specific nature of eQTLs, where 29%–80% of eQTLs are
cell type specific (Dimas et al. 2009; Nica et al. 2011; Fairfax
et al. 2012; The GTEx Consortium 2015). While eQTLs from nor-
mal tissues provide valuable insights, tissues are constituted of
multiple distinct cell types with specific gene regulatory profiles
as exemplified by eQTLs of different blood-isolated cell types
(Fairfax et al. 2012). Moreover, the collection and sampling pro-
cess of tissue samples from organs does not allow precise control
over cell representation, adding a major source of biological vari-
ability in addition to other technical variation (McCall et al.
2016). However, other than for immune cells (Kim-Hellmuth
et al. 2017), induced Pluripotent Stem Cells (iPSC) (Kilpinen
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et al. 2017), or smoothmuscle cells (Liu et al. 2018), eQTL data sets
representing single primary cell types and direct comparison of
these to the tissue type of origin have been lacking.
eQTLsmaybe particularly useful for annotating variants asso-
ciated with complex traits, as such variants are likely enriched for
eQTLs (Nicolae et al. 2010). A recent study suggested that two-
thirds of candidate common trait susceptibility genes identified
as eQTLs are not the nearest genes to the GWAS lead SNPs, high-
lighting the utility of this approach in annotating GWAS loci
(Zhu et al. 2016). Importantly, GWAS variants are enriched in
eQTLs in a tissue-specific manner. For instance, whole blood
eQTLs are enriched with autoimmune disorder-associated SNPs
but not with GWAS SNPs for bipolar disease or type 2 diabetes
(TheGTExConsortium2015). These findings highlight the impor-
tance of using eQTL data sets from relevant cell types when follow-
ing up GWAS loci for a specific disease. In addition to providing
functional insights for knownGWAS loci, eQTL datamay be useful
for identification of novel trait-associated loci via imputation of
genotype-correlated gene expression levels into GWAS data sets
(Gamazon et al. 2015; Gusev et al. 2016). Such approaches, usually
referred to as transcriptome-wide association studies (TWASs), en-
able assignments of potentially disease-associated loci via estima-
tions of their genetically regulated expression.
GWAS for melanoma risk, nevus count, and multiple pig-
mentation traits have identified numerous associated genetic loci
(Stokowski et al. 2007; Sulem et al. 2007, 2008; Brown et al. 2008;
Gudbjartsson et al. 2008; Han et al. 2008; Bishop et al. 2009;
Falchi et al. 2009; Nan et al. 2009, 2011; Duffy et al. 2010; Eriksson
et al. 2010; Amos et al. 2011; Barrett et al. 2011; Macgregor et al.
2011; Candille et al. 2012; Zhang et al. 2013; Jacobs et al. 2015;
Law et al. 2015; Liu et al. 2015; Hysi et al. 2018; Visconti et al.
2018), with melanoma GWAS alone identifying 20 regions associ-
ated with risk. Trait-associated variation explaining many of these
loci could reasonably be expected to be reflected in the biology of
the melanocyte, the pigment-producing cell in human skin and
the cellular origin of melanoma. Melanocytes are the cells in the
skin that function to produce the melanin pigments, eumelanin
and pheomelanin, in response to neuroendocrine signals and
UV-exposure (Costin and Hearing 2007). These melanin pigments
are contained in lysosome-related organelles called melanosomes,
are shuttled to themelanocyte dendrites, and transferred to neigh-
boring keratinocytes, thus protecting skin from UV radiation
(Sitaram andMarks 2012). The process of pigmentation is complex
and multigenic, and it is regulated by genes with diverse cellular
functions including those within MAPK, PI3K, Wnt/beta catenin
signaling pathways (Liu et al. 2014), as well as those involved in ly-
sosome-related functions and vesicular trafficking (Sitaram and
Marks 2012).
While several skin-related eQTL data sets are available, the
largest ones (GTEx [The GTEx Consortium 2015], MuTHER
[Nica et al. 2011], EUROBATS [Buil et al. 2015]) are derived
from heterogeneous skin tissues, of which melanocytes only
represent a small fraction. The Cancer Genome Atlas Project
(TCGA) also offers a considerable set of tumor tissue expression
data accompanied by genotype information providing a platform
for tumor-type relevant eQTL data including melanoma (https
://cancergenome.nih.gov/), but these tumor tissues contain a
high burden of somatic aberrations, are heterogeneous and may
reflect multiple disease subtypes, and may not represent the un-
derlying biology associated with cancer risk and/or pigmentation.
Given these limitations, we took advantage of the accessibility of
primary melanocytes obtained from foreskin tissues and built a
cell-type–specific eQTL data set to study the lineage-specific regu-
latory function of melanoma- and pigmentation-associated com-
mon variants.
Results
Melanocyte eQTLs are distinct from those of other tissue types
In order to create a melanocyte-specific eQTL resource, we ob-
tained primary melanocyte cultures isolated from foreskin of 106
healthy newborn males predominantly of European descent
(Supplemental Table S1). We then cultured all 106 lines following
a uniformprocedure to harvest RNAandDNA, for RNA sequencing
and genotyping, respectively (see Methods). Given the relatively
small size of our sample set, we initially focused our analysis on
local eQTLs (cis-eQTL), where we assessed the association between
expression of each gene with common variants within ±1 Mb of
transcription start sites (TSSs), following the best practices from
the GTEx project (see Methods). In all, we identified 4997
“eGenes” (genes exhibiting association with genotypes of at least
one SNP at FDR<0.05) (Supplemental Table S2) and 597,335 ge-
nome-wide “significant eQTLs” (unique SNP-gene pairs showing
FDR<0.05; SNPs were not LD-pruned), which are higher numbers
than any GTEx tissue type of similar sample size (Supplemental
Table S3). Melanocyte eGenes were enriched with Gene Ontology
(GO) terms including metabolic process, mitochondrial transla-
tion, biosynthetic process, catalytic activity, and ion-binding, as
well as lysosome and metabolic pathways (Supplemental Table
S4). Further, melanocyte eGenes included 46% of genes catego-
rized with GO terms as containing “melanin” (OCA2, TRPC1,
CTNS, DCT, MCHR1, SLC45A2, TYR, BCL2, WNT5A, MC1R, and
MYO5A) (http://amigo.geneontology.org) and 20% of curated pig-
mentation genes (based on human andmouse phenotype, OMIM,
MGI) such as IRF4, TRPM1, and MC1R (Supplemental Tables S5,
S6), reflecting pigmentation-related biology of melanocytes.
Direct comparison of significant melanocyte eQTLs with 44
GTEx tissue types indicated that the shared eQTL proportion (π1)
between melanocytes and each of the GTEx tissue types was 0.74
(vs. transformed fibroblasts) or lower, suggesting relatively low lev-
els of sharing even with two types of skin samples (π1 = 0.67 with
Skin_Sun_Exposed, and 0.58 with Skin_Not_Sun_Exposed) (Fig.
1). This contrasts with the considerably higher levels of sharing
between the two types of skin samples (π1 = 0.91) or among brain
tissues (average π1 = 0.87) inGTEx.We further focused the compar-
isonof ourmelanocyte data set to three tissue types that are directly
relevant to melanoma and pigmentation phenotypes: the two
above-mentioned GTEx skin types, as well as skin cutaneousmela-
nomas (SKCM) collected through TCGA (adding an adjustment for
localDNAcopynumber) (see SupplementalMaterial). Collectively,
these four eQTL data sets identified 12,136 eGenes, with 382
eGenes shared among all four data sets. Notably, 1801 eGenes
(36% of melanocyte eGenes) were entirely private to melanocytes,
and a total of 6187 eGenes (51% of eGenes from all four data sets)
were specific to only one of four data sets (Supplemental Fig. S1;
Supplemental Table S2). eGenes from these four data sets collec-
tively accounted for 150 of 379 (40%) curated pigmentation genes,
with the majority specific to one data set (Supplemental Fig. S2).
Melanocyte eQTLs are enriched in cis-regulatory signatures
and supported by allelic imbalance
We next sought to determine whether melanocyte eQTLs were
corroborated by allelic imbalance variants in heterozygous
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individuals from the same data set. To determine genome-wide al-
lele-specific expression (ASE), we performed binomial tests at the
single-sample level, identifying 48,038 unique allelic imbalance
variants (FDR<0.05 or effect size >0.15) (Supplemental Table
S7). Of these unique variants, 38.6% (18,532 of 48,038 variants)
were in the coding region of significant melanocyte eGenes, dem-
onstrating an enrichment of ASE in melanocyte eGenes (Fisher’s
exact test P=2.34×10−73, odds ratio = 1.82) (Supplemental Table
S7). Further, the average allelic effects of 48,038 ASE variants
from all the heterozygous individuals were significantly larger in
the eGene group (Wilcoxon signed rank test P=1.67×10−34; aver-
age |Mean AE| = 0.046 for eGenes vs. 0.035 for non-eGenes; effect
size = 0.115) (Supplemental Fig. S3A). Similarly, the proportions
of heterozygous individuals displaying
allelic imbalance at each locus was sig-
nificantly higher in the eGene group
(Wilcoxon signed rank test P=1.27×
10−81; mean %=13.4 for eGenes vs. 8.4
for non-eGenes; effect size = 0.195) (Sup-
plemental Fig. S3B).
We then further examined if mela-
nocyte eQTLs were enriched within epi-
genetic signatures marking melanocyte
cis-regulatory elements. We specifical-
ly examined regions of open chromatin
(marked by DNase I hypersensitivity
sites, DHS), as well as promoter and
enhancer histone marks (H3K27ac,
H3K4me1, and H3K4me3) generated
from primary cultured human melano-
cytes by the ENCODE and Epigenome
Roadmap Projects (www.encodeproject.
org; www.roadmapepigenomics.org) (The
ENCODE Project Consortium 2012;
Roadmap Epigenomics Consortium et
al. 2015). Indeed, higher proportions of
melanocyte eQTL SNPs were localized to
melanocyte DHS, H3K27ac, H3K4me1,
andH3K4me3peaks compared to all test-
ed SNPs (i.e., cis-SNPs ±1Mb of TSSs of all
the genes tested for eQTL) (Supplemental
Fig. S4A). Enrichment of melanocyte
eQTL SNPs for each of the melanocyte
cis-regulatory signatures was statistically
significant (P<1 ×10−4, 10,000 permuta-
tions; 1.81- to 5.48-fold) (Table 1) and
mostly more pronounced than that ob-
served in GTEx skin tissues or melanoma
tumors (Supplemental Fig. S4B; Table 1).
Enrichment of melanocyte eQTLs was
also observed in additional genomic fea-
tures (Supplemental Figs. S4, S5; Supple-
mental Material).
Melanoma GWAS signal is enriched in
melanocyte-specific genes and eQTLs
Next, we sought to determine if melano-
cyte eQTLs were enriched with common
risk variants from the most recent mela-
noma GWAS meta-analysis (Law et al.
2015). A quantile-quantile plot demon-
strated an enrichment of significant GWAS P-values for eQTL
SNPs compared to non-eQTL SNPs (Fig. 2A), which was the most
pronounced inmelanocyte eQTLs (estimated Lambda=1.51) com-
pared to three related tissue types as well as all the other GTEx tis-
sue types (Supplemental Fig. S6).
To further assess the enrichment of melanoma heritability in
melanocyte-specific expressed genes, we performed LD score re-
gression analysis (Finucane et al. 2015). The results indicated
that partitioned melanoma heritability was significantly enriched
(2.54-fold; P=2.45×10−6) in melanocyte-specific genes (top 4000
genes compared to 47GTEx tissue types) as well as in those of three
“skin” category GTEx tissue types (P=3.11×10−6, 8.62 ×10−6, and
4.37×10−5, with 2.52-, 2.58-, and 2.34-fold for not sun-exposed
Figure 1. Melanocyte eQTLs display a distinct pattern from those of 44GTEx tissue types. Dendrogram
and heat map presenting the sharing of eQTLs between human primary melanocytes and 44 other GTEx
tissue types. Pairwise π1 statistics were calculated from single-tissue eQTL discoveries in each tissue using
all the genome-wide significant eQTL SNP-gene pairs. π1 is only calculated when the gene is expressed
and testable both in discovery (columns) and replication (rows) tissues. Higher π1 values indicate an in-
creased replication of eQTLs between two tissue types. π1 values range between∼0.41 and 1 and are col-
or-coded from blue (low sharing) to red (high sharing). Tissues are clustered using the Spearman’s
correlation of π1 values. Note that π1 values are not symmetrical, since each entry in row i (replication
tissue) and column j (discovery tissue) is an estimate of π1 = Pr (eQTL in tissue i given an eQTL in tissue
j). Discovery tissue names are shown in parentheses on the bottom. The position of the skin melanocyte
eQTL data set from the discovery tissues is shown in pink.
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skin, sun-exposed skin, and transformed fibroblasts, respectively)
(Fig. 2B; Supplemental Table S8; Supplemental Fig. S7).
A functional pigmentation SNP at the IRF4 locus is a significant
trans-eQTL for four genes in melanocytes
While the modest size of this data set limits power, we also per-
formed trans-eQTL analyses for the SNPs that are located over
5 Mb away from the TSS of each gene or on a different chromo-
some. In all, we identified 15 genome-wide significant trans-
eQTL genes (excluding genes of mappability < 0.8 or overlapping
low complexity regions) (Supplemental Table S9). Of these, eight
trans-eQTL SNPs were also cis-eQTLs for local genes within 1 Mb.
Notably, rs12203592 (Chr 6: 396321), among these, is a ge-
nome-wide significant trans-eQTL SNP for four different genes
on four separate chromosomes (TMEM140, MIR3681HG, PLA1A,
and NEO1) and is also the strongest cis-eQTL SNP for the IRF4
gene (P=7.9 ×10−16, slope=−1.14), which encodes the transcrip-
tion factor, interferon regulatory factor 4. All four genes displayed
the same direction of allelic gene expression as IRF4 levels relative
to rs12203592 (Fig. 3). rs12203592 has previously been associated
with human pigmentation phenotypes (Han et al. 2008). This
variantwas also shown to be a functional SNPmediating transcrip-
tion of IRF4 in melanocytes via C allele-preferential binding of
the transcription factor, TFAP2, by collaborating with melanocyte
lineage-specific transcription factor, MITF, in turn activating the
melanin synthesis enzyme, TYR. The rs12203592-C allele (pre-
valent in African populations) is correlated with high IRF4
levels in our melanocyte data set, validating the findings observed
in a smaller sample set (Praetorius et al. 2013). Expression correla-
tion analyses in melanocytes indicated that expression levels of
TMEM140, MIR3681HG, PLA1A, and NEO1 are significantly
correlated with those of IRF4 in the same direction as shown by
trans-eQTLs (Pearson r=0.54, 0.65, 0.53, and 0.58; P=2.67×
10−9, 5.34 ×10−14, 4.28× 10−9, and 6.00×10−11, respectively)
(Supplemental Fig. S8). To assess if IRF4 expression levels mediate
the observed trans-eQTL effect for these four genes, we performed
mediation analyses using regression-based methods (Supplemen-
tal Material; Supplemental Table S10), as well as a recently pub-
lished Genomic Mediation analysis with Adaptive Confounding
adjustment (GMAC) (Yang et al. 2017). We applied the GMAC
method to 455 eSNP - cis-eGene - trans-gene trios (trans-eQTL cut-
off: P<1×10−5), 84 of which include rs12203592. A total of 121
trios displayed a suggestive mediation (P< 0.05), and 32 of them
were by IRF4 cis-eQTL including those with TMEM140 and NEO1
(Supplemental Table S11). In contrast, another cis-eQTL gene,
RPS14, sharing two SNPswith three trans-eQTL genes (Supplemen-
tal Table S9), did not show suggestive mediation (Supplemental
Table S11). These results are consistent with IRF4 expression levels
mediating at least part of the observed trans-eQTL effect. We then
sought to determine if IRF4 is predicted to bind to the genomic re-
gions encompassing the rs12203592 trans-eQTL genes. Sequence
motif enrichment analyses indicated that IRF4 binding motifs
were enriched in the genomic regions of TMEM140, MIR3681HG,
PLA1A, and NEO1 (±2 kb of gene boundary; P=1.52×10−2) (Sup-
plemental Table S12), as well as in the above-mentioned 84
trans-eQTL genes (P=7.25×10−26). Together, our data suggest a
melanocyte-specific trans-eQTL network potentially regulated by
the transcription factor, IRF4.
Melanocyte eQTLs identified candidate melanoma susceptibility
genes from GWAS loci
To assess colocalization of causal variants for melanoma GWAS
and melanocyte eQTL, we applied the previously described
eCAVIAR methodology (Hormozdiari et al. 2016). At a colocaliza-
tion posterior probability (CLPP) cutoff of 1%, five of 20 known
melanoma loci displayed colocalization of GWAS and melanocyte
eQTL signal, with colocalization of eQTL signal for nine genes
overall (Table 2; Fig. 4). The same analysis with two GTEx skin
data sets observed colocalization at combined four loci and 21
genes (Supplemental Table S13). The union of all three data sets to-
taled 29 genes from six loci, indicating that these eQTL data sets
complement each other rather than being redundant. Consistent
with a previous report (The GTEx Consortium 2017), only 66%
(four of six loci) but not all of melanoma GWAS signal colocalized
with the nearest expressed gene in one or more of the three data
sets. Importantly, melanocyte eQTLs (but not the skin data sets)
validated PARP1 as a target gene on the locus at Chr1q42.12,
which was previously characterized as a melanoma susceptibility
gene displaying melanocyte lineage-specific function (Fig. 4;
Choi et al. 2017). Melanocyte eQTLs also uniquely identified a
known pigmentation gene, SLC45A2, on the locus at 5p13.2 as a
target gene, reflecting a melanin synthesis pathway uniquely cap-
tured in melanocyte eQTLs. Consistent with previous findings,
eCAVIAR colocalization was observed for multiple genes in most
of the loci, and genes with the highest CLPP scores from different
eQTL data sets did not overlap for a given melanoma locus. In
addition, we also performed eCAVIAR analyses for GWAS of
melanoma-associated traits (number of melanocytic nevi, skin
Table 1. Enrichment of eQTL SNPs in melanocyte cis-regulatory signatures
Epigenetic marka DHS H3K27ac H3K4Me1 H3K4Me3
Melanocyte eQTLs Fold enrichmentb 1.81 5.48 1.99 3.34
P-valuec <0.0001 <0.0001 <0.0001 <0.0001
TCGA SKCM eQTLs Fold enrichmentb 1.72 2.69 1.86 3.44
P-valuec <0.0001 <0.0001 <0.0001 <0.0001
Skin not sun-exposed eQTLs Fold enrichmentb 1.78 2.77 1.92 3.5
P-valuec <0.0001 <0.0001 <0.0001 <0.0001
Skin sun-exposed eQTLs Fold enrichmentb 1.75 2.66 1.88 3.29
P-valuec <0.0001 <0.0001 <0.0001 <0.0001
aDNase I hypersensitivity sites (DHS) and gene regulatory histone marks (H3K27ac, H3K4me1, and H3K4me3) of primary melanocytes (Epigenome
Roadmap database; www.roadmapepigenomics.org).
bMean fold enrichment of eQTL SNPs over control SNP sets (with similar distribution of MAF and LD) from 10,000 permutations that are overlapping
with each epigenetic mark.
cSee Methods section.
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pigmentation, ease of tanning, and hair color), and identified
target genes from two of four nevus count loci and six of 11 pig-
mentation loci using melanocyte and skin eQTL data sets
(Supplemental Material; Supplemental Tables S14–S16).
We then performed permutation analyses to test for statisti-
cally significant enrichment of eQTLs from the four tissue types
(including TCGAmelanomas) inmelanomaGWAS using four tiers
of GWAS P-value thresholds (5 ×10−5, 5 × 10−6, 5 × 10−7, and 5×
10−8) (Supplemental Table S17). The results indicated thatmelano-
ma-associated SNPs using all four thresh-
olds are significantly enriched (at least
twofold) in eQTLs. Notably, the number
of GWAS loci displaying true overlap
was much higher (8–12 loci) for melano-
cyte eQTLs than for two types of skin tis-
sue or melanoma tumors (2–7 loci).
TWASs using melanocyte eQTL data
identified four novel melanoma-
associated loci
eQTL data can be utilized for transcrip-
tome-wide association studies to impute
gene expression levels into GWAS data
sets. We performed a TWAS (Gusev et al.
2016) using summary statistics from the
melanoma GWAS meta-analysis (Law et
al. 2015) and the melanocyte eQTL data
set as the referencedata set (seeMethods).
Using 3187 eGenes passing a conserva-
tive cutoff for heritability estimates (P<
0.01) (Supplemental Table S18), the
TWAS identified genes at three known
melanoma loci at a genome-wide signifi-
cant level (MAFF on Chr22q13.1, CTSS
on Chr1q21.3, CASP8 on Chr2q33-q34),
with a fourth locus being suggestive
(PARP1 on Chr1q42.1) (Table 3). The
TWAS further identified novel associa-
tions with melanoma at four genomic
loci at a genome-wide significant level
(ZFP90 at Chr16q22.1, HEBP1 at Chr12
p13.1, MSC and RP11-383H13.1 at
Chr8q13.3, and CBWD1 at Chr9p24.3)
(Table 3; Fig. 5).
We additionally performed a TWAS
using each of the 44 GTEx tissue types
as reference eQTL data sets. Forty-three
GTEx tissue types identified one or more
melanoma TWAS genes at a genome-
wide significant level with a median of
three genes per data set. Tibial nerve tis-
sue identified the largest numberof genes
(11 genes), while melanocytes ranked
third (Supplemental Table S19). Collec-
tively, melanocyte and GTEx data sets
identified 22 TWAS genes at six previous-
ly known melanoma GWAS loci (Chr1q
21.3, Chr1q42.1, Chr2q33-q34, Chr15q
13.1, Chr21q22.3, and Chr22q13.1) as
well as nine TWAS genes at eight novel
loci. Melanocyte eQTLs alone identified
the majority of novel TWAS genes (five of nine), including the
genes unique to the melanocyte data set (Supplemental Table
S20). In contrast, none of the 44 GTEx tissue data sets produced
more than one novel association for melanoma. Four novel mela-
noma TWAS genes added from 44 GTEx tissue types are ERCC2
on Chr19q13.32, KIF9 on Chr3p21.31, MRAP2 on Chr6q14.2,
and ZBTB4 on Chr17p13.1. Finally, we conducted conditional
analyses on the TWAS loci displayingmarginally significant associ-
ations with multiple genes frommelanocyte and GTEx tissue data
B
A
Figure 2. Melanoma GWAS signal is enriched in melanocyte-specific genes and eQTLs. (A) QQ plot
presents melanoma GWAS LD-pruned P-values of significant eQTL SNPs versus non-eQTL SNPs for the
melanocyte data set compared to those for sun-exposed skin, non-sun-exposed skin, and melanoma tu-
mors. SNPs were classified as eQTL SNPs if they were significant eQTLs or in strong LD (r2 > 0.8) with an
eQTL SNP (eQTL SNPs threshold: FDR<0.05) in each data set. The inset displays a zoomed-in view of a
lower −log10 GWAS P-value range (0–5 range for x- and y-axes). (B) Melanoma heritability enrichment
levels and P-values in top 4000 tissue-specific genes from LD score regression analysis are displayed.
The dashed horizontal line marks FDR=0.05 on the y-axis. Names of significantly enriched individual tis-
sue types are shown next to the data points, and the others are color-coded based on GTEx tissue cate-
gory. Tissue types from the “Skin” category including melanocytes are highlighted in pink.
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sets. The analyses identified 15 jointly significant genes from 14
loci (Supplemental Table S20; Supplemental Material).
Discussion
In this study, we established a cell-type–specific eQTL data set us-
ing primary cultures of human melanocytes. Our data set identi-
fied a unique set of cis- and trans-eQTLs that are distinct from
eQTLs of skin tissues. Melanocyte eQTLs are enriched in melano-
cyte-specific cis-regulatory elements and considerably improved
melanomaGWAS annotation. Using this data set, we further iden-
tified novelmelanoma TWAS loci. Our data highlight the utility of
building even a modestly sized cell-type–specific data set.
Over a third of melanocyte eGenes were unique to melano-
cytes and not present in skin tissue data sets. GO analyses suggest-
ed that genes directly involved in
melanin synthesis as well as those in ly-
sosome andmetabolic pathwayswere en-
riched in melanocyte eGenes among
others. These observations are consistent
with broad-based pleiotropic cell func-
tions for genes expressed inmelanocytes,
including lysosome-related functions of
melanin synthesis and transfer process
(Sitaram and Marks 2012). Our data set
was built with newborn males of primar-
ily European descent aiming to align
with the most relevant population for
melanoma incidence. As there are gender
differences observed in melanoma risk
and mortality among others (Scoggins
et al. 2006; Wendt et al. 2018; https://
seer.cancer.gov/faststats [accessed on
Oct. 10, 2018]), the current male-only
data set cannot address gender-specific
risk and related questions, which war-
rants future study.
Through trans-eQTL analysis, the
melanocyte data set identified IRF4, or
interferon regulatory factor 4, as a poten-
tial regulator of melanocytic lineage-
specific gene expression for a set of puta-
tive downstream genes. Trans-eQTLs
were shown to be more cell type specific
than cis-eQTLs, andcell compositionhet-
erogeneity was proposed as a potential
reason for lownumber of trans-eQTLs ob-
served in bulk tissue data (Westra and
Franke 2014; The GTEx Consortium
2017), suggesting that our single-cell-
type data set might have facilitated the
identification of the IRF4 trans-eQTL
network in melanocytes. rs12203592 is
a cis-eQTL in several other GTEx tissue
types including whole blood, perhaps re-
flecting a better known function of IRF4
in immune responses (Huber and Lohoff
2014). However, IRF4 has a documented
role inmelanocyte development, regulat-
ing expression of an enzyme essential
in the production of melanin, tyrosi-
nase (Praetorius et al. 2013). Given that
IRF4 appears to function in regulation of distinct cell-type–specific
processes, four rs12203592 trans-eQTL genes identified inmelano-
cytes, including an interferon-stimulated gene, TMEM140 (Kane
et al. 2016), as well as perhaps a considerably larger subset of mar-
ginal trans-eQTL genes, could be good candidates for direct targets
of IRF4. Further experimental assessmentof IRF4bindingon thege-
nomic regions of these trans-genes will provide additional support
of this finding.
Through colocalization and TWAS, melanocyte eQTL identi-
fied unique candidate melanoma susceptibility genes for some
known loci and also corroborated other data sets, including skin,
in identifying candidate genes for other loci. Three melanoma
loci displaying colocalization with melanocyte eQTLs were also
supported by TWASs from one or more eQTL data sets (PARP1,
ARNT, and MX2). On the other hand, some loci with larger LD
Figure 3. The pigmentation trait-associated variant, rs12203592, in IRF4 is a trans-eQTL for four genes
in melanocytes. Cis- or trans-eQTL P-values and effect sizes (β) are shown between rs12203592 and IRF4
or rs12203592 and four genome-wide significant trans-eQTL genes (TMEM140, MIR3681HG, PLA1A,
and NEO1). β values are shown relative to alternative alleles (T). Boxplots display gene expression levels
based on rs12203592 genotypes (CC, CT, and TT).
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blocks displayed variability in target gene prediction across differ-
ent data sets as well as between eCAVIAR and TWAS approaches.
For the melanoma locus at Chr1q21.3, a total of eight genes
were colocalized from three eQTL data sets, and TWASs nominated
nine genes. Each top CLPP score gene from melanocyte and skin
data sets (ARNT, CERS2, and SETDB1) were also supported by
TWASs in more than one tissue type, and TWAS joint/conditional
analyses identifiedCTSS as explaining themost of the effect in this
locus (Supplemental Material; Supplemental Fig. S9). These data
imply that multiple statistical approaches using diverse tissue
types including the cell type of disease origin is beneficial to robust
target gene prediction. Collaboration of single-cell-type andwhole
tissue eQTL was also exemplified in ASIP for hair color GWAS
colocalization (Supplemental Material).
TWASs also identified novel melanoma loci by leveraging
tissue-specific eQTL data sets and reducing the multiple testing
burden associated with GWASs. While identification of trait-as-
sociated gene expression differences via TWASs cannot be taken
to imply causality for a specific gene, TWASs may nonetheless
nominate plausible candidate risk genes at significant loci. Here,
we identified five genes at four new melanoma susceptibility
loci (ZFP90 on Chr16q22.1, HEBP1 on Chr12p13.1, MSC and
RP11-383H13.1 on Chr8q13.3, and CBWD1 on Chr9p24.3) using
melanocyte eQTLs as a reference set and four additional new
genes/loci (ERCC2,KIF9,MRAP2, andZBTB4) using 44GTEx tissue
types.
While most of these genes have known functions that might
have relevance in melanomagenesis (Supplemental Material),
ERCC2 on Chr19q13.32, among them, is a nucleotide excision
repair gene targeting UV-induced DNA damage and implicated
in Xeroderma pigmentosum (Taylor et al. 1997). MRAP2 on
Chr6q14.2 encodes melanocortin-2-receptor accessory protein 2,
which interacts with allmelanocortin receptor proteins (MCRs) to-
gether with MRAP1 to regulate cell surface expression of MCRs
(Ramachandrappa et al. 2013). Seemingly relevant functions of
these new candidate genes warrant further studies on their roles
in melanomagenesis. In all, our primary melanocyte eQTL data
set considerably advanced identification of candidate melanoma
susceptibility genes from known and newmelanoma loci through
multiple approaches, which highlights the unique value of cell-
type–specific eQTL data sets.
Methods
Melanocyte culture
We obtained frozen aliquots of melanocytes isolated from foreskin
of 106 healthy newborn males, mainly of European descent, fol-
lowing an established protocol (Halaban et al. 2000) from the
SPORE in Skin Cancer Specimen Resource Core at Yale University.
Cells were grown in lot-matchedDermalCell BasalMedium (ATCC
PCS-200-030) supplemented with lot-matched Melanocyte
Growth Kit (ATCC PCS-200-041) and 1% amphotericin B/penicil-
lin/streptomycin (120-096-711, Quality Biological) at 37°C with
5% CO2. Every step of cell culture, DNA/RNA isolation, and se-
quencing/genotyping processes was performed in rerandomized
batches. Before harvesting the cells, media was taken and tested
for mycoplasma contamination using MycoAlert PLUS mycoplas-
ma detection kit (LT07-710, Lonza). All 106 samples were negative
for mycoplasma contamination.
Genotyping and imputation
Genomic DNA was isolated from melanocytes following a
standard procedure while minimizing melanin carry-over and
genotyped on the Illumina OmniExpress arrays (HumanOmniEx-
press-24-v1-1-a) at the Cancer Genomics Research Laboratory of
the Division of Cancer Epidemiology and Genetics (NCI/NIH).
Following quality control, genotypes were imputed using Michi-
gan Imputation Server (Das et al. 2016) based on 1000 Genomes
(Phase 3, v5) reference panel (The 1000 Genomes Project
Table 2. Colocalization of melanoma GWAS and melanocyte eQTL signal
Melanoma
GWAS locus Gene SNP ID GWAS P-value CLPPa
Melanoma
GWAS lead SNPb GWAS P-valuec r2 d
Nearest
expressed genee
1q21.3 ARNT rs12410869 5.21×10−13 0.07 rs12410869 5.21×10−13 1.000 ARNT
1q21.3 ARNT rs36008098 8.55 ×10−13 0.02 rs12410869 5.21×10−13 1.000 ARNT
1q42.12 PARP1 rs9426568 3.53×10−13 1.00 rs1858550 1.68×10−13 0.996 PARP1
1q42.12 MIXL1 rs9426568 3.53×10−13 0.57 rs1858550 1.68×10−13 0.996 PARP1
1q42.12 MIXL1 rs1858550 1.68×10−13 0.25 rs1858550 1.68×10−13 1.000 PARP1
1q42.12 ADCK3 rs9426568 3.53 ×10−13 0.01 rs1858550 1.68 ×10−13 0.996 PARP1
1q42.12 PSEN2 rs9426568 3.53 ×10−13 0.01 rs1858550 1.68 ×10−13 0.996 PARP1
5p13.2 SLC45A2 rs250417 2.30×10−12 0.09 rs250417 2.30×10−12 1.000 SLC45A2
21q22.3 MX2 rs408825 3.21×10−15 0.12 rs408825 3.21×10−15 1.000 MX2
21q22.3 MX2 rs443099 3.50×10−15 0.09 rs408825 3.21×10−15 1.000 MX2
21q22.3 BACE2 rs364525 3.35 ×10−15 0.04 rs408825 3.21 ×10−15 0.996 MX2
21q22.3 BACE2 rs416981 3.28 ×10−15 0.03 rs408825 3.21 ×10−15 1.000 MX2
21q22.3 BACE2 rs408825 3.21 ×10−15 0.02 rs408825 3.21 ×10−15 1.000 MX2
21q22.3 BACE2 rs443099 3.50 ×10−15 0.02 rs408825 3.21 ×10−15 1.000 MX2
22q13.1 APOBEC3G rs132941 1.61×10−12 0.12 rs132941 1.61×10−12 1.000 PLA2G6
eCAVIAR (Hormozdiari et al. AJHG 2016) was used for testing colocalization of melanocyte eQTL and melanoma GWAS signal. Fifty SNPs upstream of
and downstream from GWAS lead SNP in each locus were chosen to quantify the probability of the variant to be causal both in GWAS and eQTL
studies.
aColocalization posterior probability (CLPP): probability that the same variant is causal in both GWAS and eQTL. Only the genes of CLPP >0.01 and
SNPs in perfect LD (r2 > 0.99 in 1KG EUR population) with the GWAS lead SNP are presented. Genes of CLPP >0.05 are shown in bold.
bThe lowest P-value SNP in the locus based on fixed effect model from Law et al. (2015) study.
cMelanoma GWAS P-value (fixed model) of the SNP in the left column.
dr2 between the SNP from the eCAVIAR analysis and the melanoma GWAS lead SNP of the given locus (1000 Genomes, EUR).
eGene whose gene body is closest to the melanoma GWAS SNP and is expressed in melanocytes at median TPM>0.
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Figure 4. Melanoma GWAS signals colocalizing with melanocyte eQTLs. (A,C,E) LocusZoom plots present the nominal eQTL P-values of all tested local
SNPs in 300- to 400-kb windows for three significant eQTL genes from three melanoma GWAS loci: (A) PARP1; (C)MX2; and (E) SLC45A2. The gene being
measured is highlighted in pink, the index melanoma risk SNP is labeled and highlighted in purple, and r2 (based on 1000G EUR) of all other SNPs to the
index SNP is color-coded. SNPs with missing LD information with the index SNP are shown in gray. Horizontal lines are shown for nominal P-value cutoffs
for significant eQTLs. Genomic coordinates are based on hg19. (B,D,F ) Boxplots present melanocyte expression differences of each gene in relation to the
genotypes of the index SNP. Melanoma risk and protective alleles are shown for each locus.
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Consortium 2015) and Mixed population, and using SHAPEIT
(Delaneau et al. 2011) for prephasing. Post-imputation genetic
variants (single nucleotide variants [SNPs and small insertion-
deletion (indel) polymorphisms) with MAF<0.01 or imputa-
tion quality scores (R-squared) <0.3 were removed from the
final analysis. Overall, ∼713,000 genotypes were obtained, and
10,718,646 genotypes were further imputed. Due to the small
sample size, we included all samples that passed genotyping QC
but histologically carry a range of African and Asian ancestry mea-
sured by ADMIXTURE (Alexander et al. 2009) analysis, while ac-
counting for ancestry in the further analyses as covariates. For
eQTL analysis, we included the top three genotyping principal
components as covariates. The principal components analysis
for population substructure was performed using the struct.pca
module of GLU (Wolpin et al. 2014), which is similar to
EIGENSTRAT (Price et al. 2006).
RNA sequencing and data processing
Cells were harvested at log phase, and total RNAwas isolated using
a miRNeasy Mini kit (217004, Qiagen) in randomized batches.
Poly(A) selected stranded mRNA libraries were constructed using
Illumina TruSeq Stranded mRNA Sample Prep kits and sequenced
onHiSeq 2500 using version 4 chemistry to achieve aminimumof
45 million 126-base paired-end reads (average of ∼87.9 million
reads). STAR (version 2.5.0b) (Dobin et al. 2013) was used for
aligning reads to the human genomic reference (hg19) with the
gene annotations from GENCODE Release 19 (https://www.
gencodegenes.org/releases/19.html). RSEM (version 1.2.31, http://
deweylab.github.io/RSEM/) was used to quantify the gene expres-
sion followed by the quantile normalization. Genes were selected
based on expression thresholds of >0.5 RSEM and ≥6 reads in at
least 10 samples. After processing, 19,608 genes were expressed
above cutoff levels in primary melanocytes. For each gene, expres-
sion values were further inverse quantile normalized to a standard
normal distribution across samples. To control for hidden batch
effects and other confounding effects that could be reflected in
the expression data, a set of covariates identified using the
Probabilistic Estimation of Expression Residuals (PEER) method
(Stegle et al. 2010) was calculated for the normalized expression
matrices. The top 15 PEER factors were determined based on the
sample size and optimizing for the number of eGenes discovered
as suggested by the GTEX project (http://www.gtexportal.org)
(15 factors for N<150).
Identification of cis-eQTLs in primary melanocytes
Cis-eQTL analysis was performed closely following a recent stan-
dard procedure adopted by GTEx (The GTEx Consortium 2017;
see Supplemental Material for details). In brief, cis-eQTL mapping
was performed using FastQTL (Ongen et al. 2016), and nominal P-
values were generated for genetic variants located within ±1Mb of
the TSSs for each gene tested. The beta distribution-adjusted em-
pirical P-values from FastQTL were then used to calculate q-values
(Storey and Tibshirani 2003), and a false discovery rate (FDR)
threshold of ≤0.05 was applied to identify genes with a significant
eQTL (“eGenes”). The effect size of the eQTLs was defined as the
slope of the linear regression and is computed as the effect of the
alternative allele (ALT) relative to the reference allele (REF). For
each gene, a nominal P-value threshold was calculated, and vari-
ants with a nominal P-value below the gene-level threshold were
considered as genome-wide significant cis-eQTL variants. The
number of identified eGenes and significant eQTLs were appro-
ximately three times higher than those from data analyzed
Table 3. Top melanoma TWAS genes using melanocyte eQTL as a reference set
Gene symbol Chr
GWAS
best SNPa
GWAS
Z-score1 b
eQTL
best SNPc
eQTL
Z-scored
GWAS
Z-score2 e
# of
SNPf
# of
weightg Modelh
TWAS
Z-score
TWAS
P-valuei
FDR
passed
GWAS
locusj
MAFF 22 rs132985 −6.91 rs738322 −5.14 −6.69 340 2 enet 6.67 2.60×10−11 Y 22q13.1
CTSS 1 rs12410869 −7.22 rs7521898 3.33 −6.42 315 6 enet −6.32 2.65×10−10 Y 1q21.3
ZFP90 16 rs7184977 5.07 rs11075688 1.06 3.96 319 319 blup 5.20 1.95×10−7 Y New
HEBP1 12 rs2111398 5.08 rs1684387 −5.32 5.08 605 5 lasso −5.05 4.48×10−7 Y New
CASP8 2 rs10931936 5.50 rs3769823 −3.71 4.45 372 3 lasso −4.61 4.06×10−6 Y 2q33-q34
MSC 8 rs1481853 −4.65 rs6983160 −3.83 −4.60 553 2 lasso 4.60 4.27×10−6 Y New
CBWD1 9 rs661356 4.79 rs2992854 4.99 −1.96 462 1 lasso −4.54 5.52×10−6 Y New
RP11-383H13.1 8 rs1481853 −4.65 rs6983160 −2.75 −4.60 693 4 lasso 4.50 6.68×10−6 Y New
GPRC5A 12 rs2111398 5.08 rs1684387 −4.02 5.08 584 11 enet −4.19 2.80 × 10−5 N New
RBBP5 1 rs11240466 4.09 rs10900456 1.41 3.98 623 623 blup 3.59 3.37 × 10−4 N New
ATP6V1G2-
DDX39B
6 rs2239704 4.55 rs2523504 3.51 3.54 278 1 lasso 3.54 3.97 × 10−4 N New
CDH1 16 rs7184977 5.07 rs4076177 2.71 4.52 345 345 blup 3.47 5.27 × 10−4 N New
CHCHD6 3 rs9851451 3.46 rs9822602 −2.73 3.44 635 3 lasso −3.44 5.78 × 10−4 N New
CTD-2003C8.2 11 rs1554519 4.51 rs7932891 5.66 3.32 746 4 lasso 3.43 6.08 × 10−4 N New
UQCC1 20 rs2425025 6.95 rs6060369 −3.14 −3.00 353 353 blup 3.42 6.21 × 10−4 N New
PLXNA1 3 rs9851451 3.46 rs4679317 −2.20 3.42 484 2 lasso −3.42 6.33 × 10−4 N New
PARP1 1 rs1865222 −7.12 rs3219090 −1.30 −6.86 404 404 blup 3.41 6.57 × 10−4 N 1q42.12
arsID of the most significant melanoma GWAS SNP for the TWAS gene after QC and IMPG imputation by FUSION program.
bGWAS Z-score of the most significant GWAS SNP in the locus.
crsID of the best eQTL SNP in the locus.
deQTL Z-score of the best eQTL SNP in the locus.
eGWAS Z-score for the best eQTL SNP.
fNumber of SNPs in the locus.
gWeighted number of SNPs in the locus.
hBest performing model.
iTWAS P-value (genome-wide significant P-values are in bold).
jPreviously identified GWAS locus (shaded) or newly identified by this study.
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without using PEER factors as covariates
(Supplemental Table S2). Application of
PEER factors almost doubled the number
of eGenes known to be related to pig-
mentation phenotypes (0.8% vs. 1.5%;
Fisher’s exact test P-value=0.0335).
Pairwise eQTL sharing between
primary melanocytes and 44 GTEx
tissues
To test the sharing of all significant SNP-
gene pairs of our melanocyte eQTL study
with those identified in 44 tissue types by
GTEx (FDR<0.05) (The GTEx Con-
sortium 2013; The GTEx Consortium
2017), we calculated pairwise π1 statistics
(indicating the proportion of true posi-
tives) using Storey’s QVALUE software
(https://github.com/StoreyLab/qvalue)
(Storey and Tibshirani 2003). A heat map
was drawn based on the pairwise π1 val-
ues, where higher π1 values indicate an
increased replication of eQTLs. Tissues
are grouped using hierarchical clustering
on rows and columns separately with a
distance metric of 1− ρ, where ρ is the
Spearman’s correlation of π1 values. π1 is
only calculated when the gene is ex-
pressed and testable in both the discov-
ery and the replication tissues.
Identification of trans-eQTLs in primary
melanocytes
Trans-eQTL analysis was performed for
SNPs that are located over 5 Mb away
from the TSS of each gene or on a differ-
ent chromosome. Genes of mappability
<0.8 or overlapping low complexity re-
gions defined by the RepeatMasker
(Smit et al. 2013–2015) library were ex-
cluded from the analysis. The nominal
P-values for gene-SNP pairs in trans-
eQTL analysis were calculated using
Matrix-eQTL (Shabalin 2012). We per-
formed a permutation test followed by
the Benjamini–Hochberg procedure to
identify significant trans-eQTLs follow-
ing our previous approach (Shi et al.
2014). For each nominal P-value thresh-
old p, we calculated the number of genes
(denoted as N1(p)) that have at least one
SNP in its trans region with nominal P-
value less than the threshold p. Here,
N1(p) denotes the number of trans-eQTL
genes at P-value threshold p. Next, we
performed 100 permutations to estimate
the number of genes (denoted as N0(p))
detected to have trans-eQTL signals at
nominal P-value p under the global null
hypothesis. By definition, one can calcu-
late the FDR as FDR=N0(p)/N1(p). We
chose p=3.25×10−11 to control FDR at
a desired level of 0.1.
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Figure 5. TWAS using melanocyte eQTL data as a reference set identified five new melanoma-associ-
ated genes in four new loci. (A) The new melanoma TWAS gene, ZFP90 on Chromosome 16 (TWAS P=
1.95 ×10−7, TWAS Z=5.2) is shown in green, along with a secondmarginally significant gene, CDH1 (P=
5.27 ×10−4, Z=3.47) in blue, and other annotated genes at the locus (coordinates are hg19). The
Manhattan plot presents the melanoma GWAS P-values before (gray) and after (blue) conditioning on
imputed melanocyte-specific gene expression of the gene in green (ZFP90 in this locus). (B) A similar
plot for the melanoma TWAS gene HEBP1 (TWAS P=4.65 ×10−7, TWAS Z=−5.04) and a secondmargin-
ally significant gene, GPRC5A (TWAS P=2.8 × 10−5, TWAS Z =−4.19) on chromosome band 12p13.1.
(C ) A similar plot for two new melanoma TWAS genes, MSC (P=4.27 ×10−6, Z=4.6) and RP11-
383H13.1 (P=6.68 ×10−6, Z=4.5) on chromosome band 8q13.3. The Manhattan plot shows the mel-
anoma GWAS P-values before (gray) and after (blue) conditioning on imputed melanocyte-specific gene
expression ofMSC. (D) A similar plot of new melanoma TWAS gene, CBWD1 (P=5.52 ×10−6, Z =−4.54)
and a marginally significant gene, DOCK8 (P=2.7 ×10−3, Z=2.99) on chromosome band 9p24.3.
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Identifying cis-mediators for trans-eQTLs in primary melanocytes
We applied the Genomic Mediation analysis with Adaptive
Confounding adjustment (Yang et al. 2017) algorithm to identify
cis-mediators for trans-eQTLs in primary melanocyte eQTL data.
Only the trios with evidence of both cis and trans association
were kept. The cis-eQTL SNP with the smallest P-value for each
gene (eQTL FDR<0.05) and trans-association P-value <10−5 was
selected as one trio. Up to five PEER factors and other covariates
(top 10 genotype PCs) were adjusted. One hundred thousand per-
mutations for testing mediation were performed, and trios with
suggestive mediation were reported using a mediation P-value
threshold <0.05.
Allele-specific expression
ASE analysis was performed based on the GATK best practices
pipeline in allelic expression analysis published by the Broad
Institute (Castel et al. 2015; see Supplemental Material for details).
Following quality control, we evaluated the significance of allelic
imbalance using a binomial test in each individual level, compar-
ing the observed to the subject- and genotype-specific expected al-
lele ratios (Ongen et al. 2014), while accounting for base-specific
mapping bias (Lappalainen et al. 2013; Zhang et al. 2018). In
addition, the effect size of allelic expression (AE, defined as
|0.5-Reference ratio|) was calculated. We defined significant ASE
genes as genes with at least one genetic variant exhibiting a mini-
mum effect size of 0.15 or a significant difference from the expect-
ed allele ratio of 0.5 at FDR<0.05 (calculated using the Benjamini
and Hochberg approach) (Benjamini and Hochberg 1995) in one
or more individuals. Significant ASE genes were then grouped
into melanocyte eGenes and non-eGenes, and |Mean AE| values
as well as percentage of individuals displaying allelic imbalance
were compared between two groups (Wilcoxon rank-sum and
signed ranked tests).
Assessing enrichment in putative functional elements
To assess the enrichment of cis-eQTL in putative functional ele-
ments of primary melanocytes, we collected the DNase-seq and
ChIP-seq data from the Epigenome Roadmap Project (http://
www.roadmapepigenomics.org) (Roadmap Epigenomics Consor-
tium et al. 2015). For each putative functional element, wemerged
peak callings from all samples into one, and all the significant me-
lanocyte eQTL SNP-Gene pairs were used for the enrichment anal-
yses using a similar method to a recent publication (Zhang et al.
2018). Briefly, we performed randomizations for testing whether
an eQTL SNP set is enriched for given histone mark regions.
Note the following procedure controls for the distribution of mi-
nor allele frequencies of a given eQTL SNP set: (1) For K eQTL
SNPs, we determined the number (denoted as X0) of eQTL SNPs
functionally related with the histone mark. (2) We randomly sam-
pled 10,000 SNP sets. Each SNP set had K SNPs in linkage equilib-
rium, with minor allele frequency distribution similar to the
original K eQTL SNPs. For the nth sampled SNP set, we calculated
the number (denoted as xn) of SNPs functionally related with the
histone mark. We had {x1, …, x10,000}, corresponding to the sam-
pled 10,000 SNP sets. (3) Enrichment fold change was calculated
as FC = (X0/(
∑10,000
n=1 xn/10, 000)), where the denominator repre-
sented the average number of SNPs functionally related with the
histone mark under the null hypothesis. The P-value for enrich-
ment was calculated as P= {n:xn≥X0}/10, 000, i.e., the proportion
of SNP sets functionally more related with the histone mark
than the given eQTL SNP set. If xn<X0 for all sample SNP sets,
we reported the P value as P< 10−4. In addition, we also assessed
enrichment of cis-eQTLs in different genomic regions including
5′/3′ UTR, promoter, exon, intron, and intergenic and lncRNA re-
gions as described in the R annotatr package (https://github.com/
hhabra/annotatr) (Cavalcante and Sartor 2017).
Enrichment of melanoma GWAS variants in eQTLs
Two methods were used to evaluate if the melanoma GWAS vari-
ants were enriched in eQTLs of different data sets. First, QQ plots
were used to show the differences in melanoma association P-val-
ues from the most recent meta-analysis (Law et al. 2015) between
the significant eQTL SNPs and non-eQTL SNPs. For all GWAS var-
iants, we first performed LD pruning using PLINK (r2 = 0.1 and
window size 500 kb) (Purcell et al. 2007). If a pruned SNP is an
eQTL or is in LD (r2 > 0.8) with an eQTL SNP, the SNP is classified
as an eQTL SNP. Otherwise, it is classified as a non-eQTL SNP. The
lambda values were estimated using the “estlambda2” function in
R package “QQperm” (https://github.com/cran/QQperm). For the
second method, a simulation procedure was applied to identify
overlap and test for enrichment of eQTLs in melanoma GWAS
SNPs closely following a previously published method (Hannon
et al. 2016; see Supplemental Material for details).
Melanoma heritability enrichment of tissue-specific genes
We used stratified LD score regression implemented in the LDSC
program (https://github.com/bulik/ldsc) to estimate the en-
richment of melanoma heritability for SNPs around tissue and
cell-type–specific genes as described previously (Finucane et al.
2018). In brief, to reduce batch effects, RNA-seq data for both
GTEx tissues and our melanocytes were quantified as RPKM using
RNA-SeQC (v1.18) (DeLuca et al. 2012) followed by quantile nor-
malization. To define the tissue-specific genes, we calculated the
t-statistic of each gene for a given tissue, excluding all samples
from the same tissue category (we treated the tissue category for
melanocytes as “Skin”) (see Supplemental Table S8 and Supple-
mental Material for details). We selected the top 1000, 2000, and
4000 tissue-specific genes by t-statistic, added a 100-kb window
around their transcribed regions to define tissue-specific genome
annotation, and applied stratified LD score regression on a joint
SNP annotation to estimate the heritability enrichment against
the melanoma GWAS meta-analysis (Law et al. 2015). The results
using the top 4000 tissue-specific genes showed significant enrich-
ment (FDR<0.05) for melanocyte and all three tissue types in the
“Skin” category. The overall pattern was consistently observed in
results using 2000 and 1000 genes, while melanocyte was signifi-
cant in results from 2000 but not in those from 1000 genes
(Supplemental Table S8; Supplemental Fig. S7). Importantly,
some of the top enriched tissues outside of the “Skin” category
(e.g., Colon_Transverse) displayed high median expression level
correlation with melanocytes (Pearson’s r=0.95 between melano-
cyte and Colon_Transverse) (Supplemental Fig. S10).
Colocalization analysis of GWAS and eQTL data
We performed colocalization analysis for 20 GWAS loci from the
most recent GWAS meta-analysis using CAusal Variants
Identification in Associated Regions (eCAVIAR, http://genetics.cs.
ucla.edu/caviar/index.html) (Hormozdiari et al. 2016). For each lo-
cus, both GWAS and eQTL summary statistics (from our melano-
cyte data set and two GTEx skin tissues) of selected variants in
that locus were extracted as the input for eCAVIAR. We selected
50 SNPs both upstream of and downstream from the GWAS lead
SNP for each GWAS locus. We computed the CLPP score with a
maximum number of two causal SNPs in each locus. We used a
CLPP>1% (0.01) cutoff for colocalization. Thus, for a given
GWAS variant (either the lead SNP itself or the SNPs in near perfect
Cell-type–specific melanocyte eQTL data set
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LD with the lead SNP using the cutoff r2 > 0.99), an eGene with a
CLPP score above the colocalization cutoff is considered a target
gene. We also highlight the eGenes with CLPP>0.05 as they
were more robust across minor changes in analyses criteria com-
pared to those on the borderline (between 0.01 and 0.05) in our
analyses.
Performing TWASs with GWAS summary statistics
We performed 45 transcriptome-wide association studies by pre-
dicting the function/molecular phenotypes into GWAS usingmel-
anoma GWAS summary statistics and both GTEx and melanocyte
RNA-seq expression data. TWAS/FUSION (http://gusevlab.org/
projects/fusion/) was used to perform the TWAS analysis, allowing
for multiple prediction models, independent reference LD, addi-
tional feature statistics, and cross-validation results (Gusev et al.
2016). In brief, we collected the summary statistics including
no significance thresholding from the most recently published
cutaneousmelanomameta-analysis (Law et al. 2015). The precom-
puted expression reference weights for GTEx gene expression (V6)
RNA-seq across 44 tissue types were downloaded from the TWAS/
FUSION website (http://gusevlab.org/projects/fusion/). We com-
puted functional weights from our melanocyte RNA-seq data one
gene at a time. Genes that failed quality control during a heritabil-
ity check (using minimum heritability P-value of 0.01) were ex-
cluded from the further analyses. We restricted the cis-locus to
500 kb on either side of the gene boundary. A genome-wide sig-
nificance cutoff (TWAS P-value <0.05/number of genes tested)
was applied to the final TWAS result. Multiple associated features
in a locus were observed, and thus we performed the joint/con-
ditional analysis to identify which are conditionally independent
for each melanoma susceptibility locus using a permutation test
with a maximum of 100,000 permutations and initiate permuta-
tion P-value threshold of 0.05 for each feature. We also checked
howmuch GWAS signal remained after conditioning on imputed
expression levels of each associated feature by using “FUSION.
post_process.R” script.
Other analyses
IRF4 motif enrichment analyses were performed using the
AME module in The MEME Suite (http://meme-suite.org) (Bailey
et al. 2009) and inputted shuffled sequences as control. IRF4motifs
were downloaded from HOCOMOCO v10 database (http://
hocomoco.autosome.ru/motif/IRF4_HUMAN.H10MO.C) (Kula-
kovskiy et al. 2013). All the statistical analyses were performed in
R (R Core Team 2018).
Reference genome build statement
Our data were mapped to GRCh37/hg19 to allow maximum com-
parability with the GTEx and other public data sets we used in the
manuscript. Mapping the reads of our data to the most current
GRCh38 would not significantly affect the global eQTL analyses
and conclusions of the current paper, and only minor differences
are expected.
Data access
Genotyping and RNA sequencing data of 106 primary human
melanocytes as well as processed eQTL data from this study have
been submitted to the database of Genotypes and Phenotypes
(dbGAP, https://www.ncbi.nlm.nih.gov/gap) under accession
number phs001500.v1.p1.
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